Cell Source, Inc.: 10-K filed 2018-07-25
What Cell Source, Inc. reported in its annual report filed 2018-07-25 (fiscal FY 2017): 24 published measures, 72 facts as tagged in accession 0001165527-18-000154.
This filing
- Form
- 10-K (annual report)
- Filed
- 2018-07-25
- Fiscal period
- fiscal FY 2017
- Accession
- 0001165527-18-000154 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cell Source, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 531,677 | USD | |
| At 2016-12-31 | 211,103 | USD | |
| At 2015-12-31 | 214,829 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 5,089,051 | USD | |
| At 2016-12-31 | 6,454,052 | USD | |
| At 2015-12-31 | 5,973,078 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | -4,557,374 | USD | |
| At 2016-12-31 | -6,242,949 | USD | |
| At 2015-12-31 | -5,758,249 | USD | |
| At 2014-12-31 | -3,783,728 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 371,048 | USD | |
| At 2016-12-31 | 3,735 | USD | |
| At 2015-12-31 | 6,944 | USD | |
| At 2014-12-31 | 19,480 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | -3,082,510 | USD | 365 |
| 2016-01-01 to 2016-12-31 | -967,782 | USD | 366 |
| 2015-01-01 to 2015-12-31 | -2,504,105 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | -2,287,814 | USD | 365 |
| 2016-01-01 to 2016-12-31 | -1,494,060 | USD | 366 |
| 2015-01-01 to 2015-12-31 | -2,000,610 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 2,655,127 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 1,490,851 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 1,988,074 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | -14,552,887 | USD | |
| At 2016-12-31 | -11,470,377 | USD | |
| At 2015-12-31 | -10,502,595 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 0 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 0 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 0 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 407 | USD | |
| At 2015-12-31 | 1,267 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 44,719 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 114,759 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 135,884 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 901,300 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 531,677 | USD | |
| At 2016-12-31 | 210,696 | USD | |
| At 2015-12-31 | 213,562 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 174,970 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 243,425 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 32,612 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 5,089,051 | USD | |
| At 2016-12-31 | 6,454,052 | USD | |
| At 2015-12-31 | 5,924,936 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 2,292,803 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 2,318,606 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 2,320,475 | USD | 365 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 815,947 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 951,783 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 1,097,580 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 637,318 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 554,185 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 392,925 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 25,349,236 | shares | |
| At 2016-12-31 | 24,679,256 | shares | |
| At 2015-12-31 | 23,929,256 | shares |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 50,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 2,582 | USD | |
| At 2016-12-31 | 2,175 | USD | |
| At 2015-12-31 | 1,315 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 821,244 | USD | |
| At 2016-12-31 | 875,211 | USD | |
| At 2015-12-31 | 441,485 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 0 | USD | |
| At 2016-12-31 | 0 | USD | |
| At 2015-12-31 | 0 | USD |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 407 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 860 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 860 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | -789,707 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 1,350,824 | USD | 366 |
| 2015-01-01 to 2015-12-31 | -183,630 | USD | 365 |
Inspect the source
- Entity
- Cell Source, Inc. / CIK 0001569340
- Captured
- 2026-09-20T09:20:59.488Z
- SEC response SHA-256
a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))